Ability Pharma

Ability Pharma

AbilityPharma is a clinical stage phase 2b biopharmaceutical company focused on autophagy to treat cancer. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

€1.0m

Early VC
*

€1.2m

Seed
*

€3.5m

Early VC

€2.3m

Grant

€1.6m

Grant

€2.0m

Seed

€850k

Early VC
*

€7.0m

Valuation: €27.7m

Early VC
Total Funding$21.5m

Recent News about Ability Pharma

Edit
More about Ability Pharma
Edit

Developer of medical therapies intended to focus on developing fully differentiated oral targeted anticancer compounds. The company's targeted therapies are drugs that kill cancer cells through the induction of robust cytotoxic autophagy, enabling doctors to improve the lives of the patients and cure them.

Keywords: Pharmaceuticals and Biotechnology, Biopharmaceutical Company, Cancer Care, Cancer Drug Discovery, Cell Membrane, Gynecological Cancer, Healthcare Services, Therapeutic Strategy.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.